XML 93 R57.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholder's equity (Details)
1 Months Ended 12 Months Ended
Nov. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
shares
May 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
vote
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Oct. 31, 2020
$ / shares
shares
Subsidiary, Sale of Stock [Line Items]            
Preferred stock, shares authorized | shares       10,000,000 10,000,000 10,000,000
Common stock, shares authorized | shares       150,000,000 150,000,000 150,000,000
Common stock, par value (in dollars per share) | $ / shares       $ 0.0001 $ 0.0001 $ 0.0001
Preferred stock, par value (in dollars per share) | $ / shares       $ 0.0001 $ 0.0001 $ 0.0001
Common stock, number of votes per share | vote       1    
Proceeds from follow-on public offering | $       $ 0 $ 169,465,000  
Issuance and sale of common stock | $         169,465,000  
At-the-market offerings | Equity Distribution Agreement with Cowen and Company, LLC            
Subsidiary, Sale of Stock [Line Items]            
Issuance and sale of common stock | $       $ 0 $ 0  
Maximum | At-the-market offerings | Equity Distribution Agreement with Cowen and Company, LLC            
Subsidiary, Sale of Stock [Line Items]            
Issuance and sale of common stock | $ $ 200,000,000          
Common Stock            
Subsidiary, Sale of Stock [Line Items]            
Common stock offering, net of issuance costs (in shares) | shares         4,887,500  
Exercise price per share (in dollars per share) | $ / shares     $ 8.86      
Aggregate exercise price | $     $ 3,000,000      
Shares issued upon warrant exercise—related party (in shares) | shares     256,038   256,038  
Issuance and sale of common stock | $         $ 1,000  
Common Stock | Follow-on public offering            
Subsidiary, Sale of Stock [Line Items]            
Common stock offering, net of issuance costs (in shares) | shares   4,887,500        
Proceeds from follow-on public offering | $   $ 169,500,000        
Common Stock | Follow-on public offering | Underwriters for IPO exercised in full overallotment option            
Subsidiary, Sale of Stock [Line Items]            
Common stock offering, net of issuance costs (in shares) | shares   637,500        
Common Stock | Maximum            
Subsidiary, Sale of Stock [Line Items]            
Warrant issued to purchase shares (in shares) | shares     338,784